Lupus & You is a free educational series where people with lupus and their family and friends can learn more about the latest in lupus research and managing the disease. Our Health Education ...

Find out more about lupus: the symptoms, types, causes, and who is at risk for developing this chronic autoimmune disease.

I know my story isn’t over yet — I take it one day at a time and keep fighting. Lupus may be part of my life, but it does not define all of who I am.

The U.S. Food and Drug Administration has approved Saphnelo™ (anifrolumab-fnia) for use as a treatment for adults with systemic lupus erythematosus (SLE).

We answer some of the most common questions we receive about Saphnelo, the therapy for systemic lupus erythematosus.

In Washington, DC and state capitals around the country, Lupus Foundation of America advocates tell their stories and urge their elected officials to support policies that improve the lives of people ...

Cullinan Therapeutics has announced a licensing agreement with Genrix Bio for global rights to velinotamig, a clinical-stage BCMAxCD3 bispecific T cell engager.

Read the details on how the Lupus Foundation of America estimates that 1.5 million Americans have lupus.